314 related articles for article (PubMed ID: 8573621)
21. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.
Gill DR; Southern KW; Mofford KA; Seddon T; Huang L; Sorgi F; Thomson A; MacVinish LJ; Ratcliff R; Bilton D; Lane DJ; Littlewood JM; Webb AK; Middleton PG; Colledge WH; Cuthbert AW; Evans MJ; Higgins CF; Hyde SC
Gene Ther; 1997 Mar; 4(3):199-209. PubMed ID: 9135733
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
Zabner J; Couture LA; Gregory RJ; Graham SM; Smith AE; Welsh MJ
Cell; 1993 Oct; 75(2):207-16. PubMed ID: 7691415
[TBL] [Abstract][Full Text] [Related]
23. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
Hyde SC; Southern KW; Gileadi U; Fitzjohn EM; Mofford KA; Waddell BE; Gooi HC; Goddard CA; Hannavy K; Smyth SE; Egan JJ; Sorgi FL; Huang L; Cuthbert AW; Evans MJ; Colledge WH; Higgins CF; Webb AK; Gill DR
Gene Ther; 2000 Jul; 7(13):1156-65. PubMed ID: 10918483
[TBL] [Abstract][Full Text] [Related]
24. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro.
Zabner J; Couture LA; Smith AE; Welsh MJ
Hum Gene Ther; 1994 May; 5(5):585-93. PubMed ID: 7519884
[TBL] [Abstract][Full Text] [Related]
25. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.
Harvey BG; Leopold PL; Hackett NR; Grasso TM; Williams PM; Tucker AL; Kaner RJ; Ferris B; Gonda I; Sweeney TD; Ramalingam R; Kovesdi I; Shak S; Crystal RG
J Clin Invest; 1999 Nov; 104(9):1245-55. PubMed ID: 10545523
[TBL] [Abstract][Full Text] [Related]
26. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
[No Abstract] [Full Text] [Related]
27. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
[TBL] [Abstract][Full Text] [Related]
28. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium.
Perricone MA; Morris JE; Pavelka K; Plog MS; O'Sullivan BP; Joseph PM; Dorkin H; Lapey A; Balfour R; Meeker DP; Smith AE; Wadsworth SC; St George JA
Hum Gene Ther; 2001 Jul; 12(11):1383-94. PubMed ID: 11485630
[TBL] [Abstract][Full Text] [Related]
29. Ability of adenovirus vectors containing different CFTR transcriptional cassettes to correct ion transport defects in CF cells.
Jiang C; O'Connor SP; Armentano D; Berthelette PB; Schiavi SC; Jefferson DM; Smith AE; Wadsworth SC; Cheng SH
Am J Physiol; 1996 Oct; 271(4 Pt 1):L527-37. PubMed ID: 8897899
[TBL] [Abstract][Full Text] [Related]
30. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
[No Abstract] [Full Text] [Related]
32. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.
Zabner J; Cheng SH; Meeker D; Launspach J; Balfour R; Perricone MA; Morris JE; Marshall J; Fasbender A; Smith AE; Welsh MJ
J Clin Invest; 1997 Sep; 100(6):1529-37. PubMed ID: 9294121
[TBL] [Abstract][Full Text] [Related]
33. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.
Porteous DJ; Dorin JR; McLachlan G; Davidson-Smith H; Davidson H; Stevenson BJ; Carothers AD; Wallace WA; Moralee S; Hoenes C; Kallmeyer G; Michaelis U; Naujoks K; Ho LP; Samways JM; Imrie M; Greening AP; Innes JA
Gene Ther; 1997 Mar; 4(3):210-8. PubMed ID: 9135734
[TBL] [Abstract][Full Text] [Related]
34. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.
Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z
Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335
[TBL] [Abstract][Full Text] [Related]
35. Ability of a chimeric cAMP-responsive promoter to confer pharmacologic control of CFTR cDNA expression and cAMP-mediated Cl- secretion.
Suzuki M; Singh RN; Crystal RG
Gene Ther; 1997 Nov; 4(11):1195-201. PubMed ID: 9425443
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA.
Mittereder N; Yei S; Bachurski C; Cuppoletti J; Whitsett JA; Tolstoshev P; Trapnell BC
Hum Gene Ther; 1994 Jun; 5(6):717-29. PubMed ID: 7948134
[TBL] [Abstract][Full Text] [Related]
37. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
[TBL] [Abstract][Full Text] [Related]
38. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.
Bout A; Imler JL; Schultz H; Perricaudet M; Zurcher C; Herbrink P; Valerio D; Pavirani A
Gene Ther; 1994 Nov; 1(6):385-94. PubMed ID: 7584104
[TBL] [Abstract][Full Text] [Related]
39. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
[TBL] [Abstract][Full Text] [Related]
40. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
